AUPH vs. NXT
Compare and contrast key facts about Aurinia Pharmaceuticals Inc. (AUPH) and Nextracker Inc (NXT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AUPH or NXT.
Correlation
The correlation between AUPH and NXT is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AUPH vs. NXT - Performance Comparison
Key characteristics
AUPH:
1.30
NXT:
0.03
AUPH:
2.13
NXT:
0.57
AUPH:
1.24
NXT:
1.06
AUPH:
0.67
NXT:
0.06
AUPH:
4.00
NXT:
0.10
AUPH:
14.28%
NXT:
31.11%
AUPH:
44.59%
NXT:
59.35%
AUPH:
-87.58%
NXT:
-48.61%
AUPH:
-75.48%
NXT:
-26.88%
Fundamentals
AUPH:
$1.13B
NXT:
$6.37B
AUPH:
$0.04
NXT:
$4.05
AUPH:
206.50
NXT:
10.67
AUPH:
0.00
NXT:
3.70
AUPH:
4.77
NXT:
2.25
AUPH:
2.97
NXT:
4.31
AUPH:
$184.83M
NXT:
$2.03B
AUPH:
$164.33M
NXT:
$703.14M
AUPH:
$32.49M
NXT:
$473.26M
Returns By Period
In the year-to-date period, AUPH achieves a -9.69% return, which is significantly lower than NXT's 21.33% return.
AUPH
-9.69%
12.64%
-2.76%
57.48%
-14.21%
7.84%
NXT
21.33%
21.69%
7.67%
1.81%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AUPH vs. NXT — Risk-Adjusted Performance Rank
AUPH
NXT
AUPH vs. NXT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Aurinia Pharmaceuticals Inc. (AUPH) and Nextracker Inc (NXT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AUPH vs. NXT - Dividend Comparison
Neither AUPH nor NXT has paid dividends to shareholders.
Drawdowns
AUPH vs. NXT - Drawdown Comparison
The maximum AUPH drawdown since its inception was -87.58%, which is greater than NXT's maximum drawdown of -48.61%. Use the drawdown chart below to compare losses from any high point for AUPH and NXT. For additional features, visit the drawdowns tool.
Volatility
AUPH vs. NXT - Volatility Comparison
The current volatility for Aurinia Pharmaceuticals Inc. (AUPH) is 9.62%, while Nextracker Inc (NXT) has a volatility of 14.20%. This indicates that AUPH experiences smaller price fluctuations and is considered to be less risky than NXT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AUPH vs. NXT - Financials Comparison
This section allows you to compare key financial metrics between Aurinia Pharmaceuticals Inc. and Nextracker Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AUPH vs. NXT - Profitability Comparison
AUPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Aurinia Pharmaceuticals Inc. reported a gross profit of 54.32M and revenue of 59.87M. Therefore, the gross margin over that period was 90.7%.
NXT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Nextracker Inc reported a gross profit of 240.90M and revenue of 679.36M. Therefore, the gross margin over that period was 35.5%.
AUPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Aurinia Pharmaceuticals Inc. reported an operating income of -1.67M and revenue of 59.87M, resulting in an operating margin of -2.8%.
NXT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Nextracker Inc reported an operating income of 150.24M and revenue of 679.36M, resulting in an operating margin of 22.1%.
AUPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Aurinia Pharmaceuticals Inc. reported a net income of 1.43M and revenue of 59.87M, resulting in a net margin of 2.4%.
NXT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Nextracker Inc reported a net income of 115.28M and revenue of 679.36M, resulting in a net margin of 17.0%.